Skip to main content

Table 3 Comparison at baseline among the female subsample: ANOVA

From: Athletes with eating disorders: clinical-psychopathological features and gender differences

 

HC

ED-A

ED+A

HC versus

HC versus

ED-A versus

η2

(n = 50)

(n = 50)

(n = 50)

ED-A

ED+A

ED+A

Mean

SD

Mean

SD

Mean

SD

p

|d|

p

|d|

p

|d|

EDI-2 Drive thinness

3.42

4.36

14.36

5.99

13.72

7.50

0.001*

2.09†

0.001*

1.68†

0.871

0.09

0.409

EDI-2 Body dissatisfaction

9.40

7.63

18.12

8.00

15.36

9.31

0.001*

1.11†

0.002

0.70†

0.258

0.32

0.162

EDI-2 Interoc. awareness

2.82

2.69

9.72

7.26

10.52

7.42

0.001*

1.26†

0.001*

1.38†

0.812

0.11

0.241

EDI-2 Bulimia

1.00

1.37

5.98

5.47

5.88

5.18

0.001*

1.25†

0.001*

1.29†

0.994

0.02

0.220

EDI-2 Interpers. distrust

3.98

3.60

5.34

4.15

5.16

4.74

0.271

0.35

0.373

0.28

0.977

0.04

0.021

EDI-2 Ineffectiveness

3.44

3.23

9.74

6.43

10.38

7.60

0.001*

1.24†

0.001*

1.19†

0.869

0.09

0.215

EDI-2 Maturity fears

4.20

3.46

7.32

5.61

7.68

6.12

0.013*

0.67†

0.004*

0.70†

0.942

0.06

0.085

EDI-2 Perfectionism

2.98

2.93

5.22

4.38

7.32

5.31

0.037*

0.60†

0.001*

1.01†

0.055

0.43

0.146

EDI-2 Impulse regulation

1.62

3.29

5.58

5.69

6.04

6.17

0.001*

0.85†

0.001*

0.89†

0.907

0.08

0.129

EDI-2 Ascetic

2.16

1.69

7.20

4.24

7.88

5.23

0.001*

1.56†

0.001*

1.47†

0.698

0.14

0.292

EDI-2 Social Insecurity

3.50

3.55

6.72

4.28

7.14

5.83

0.003*

0.82†

0.001*

0.75†

0.903

0.08

0.111

EDI-2 Total scale

38.52

15.72

95.30

38.71

97.10

53.32

0.001*

1.92†

0.001*

1.49†

0.974

0.04

0.330

SCL-90R Somatization

1.32

0.86

1.76

0.87

1.60

0.98

0.059

0.50†

0.301

0.31

0.699

0.17

0.039

SCL-90R Obses.-compul.

1.05

0.74

1.73

0.78

1.80

0.95

0.001*

0.90†

0.001*

0.89†

0.903

0.09

0.148

SCL-90R Int.sensitivity

0.96

0.73

2.07

0.89

1.91

1.05

0.001*

1.36†

0.001*

1.04†

0.656

0.17

0.231

SCL-90R Depression

1.16

0.80

2.20

0.76

2.07

1.03

0.001*

1.33†

0.001*

0.99†

0.761

0.14

0.225

SCL-90R Anxiety

0.97

0.75

1.65

0.79

1.62

0.90

0.001*

0.88†

0.001*

0.78†

0.983

0.04

0.130

SCL-90R Hostility

0.55

0.65

1.40

1.07

1.27

0.89

0.001*

0.95†

0.001*

0.92†

0.770

0.13

0.152

SCL-90R Phobic anxiety

0.63

0.79

0.99

0.76

0.99

1.08

0.129

0.47

0.128

0.38

1.000

0.00

0.036

SCL-90R Paranoia

0.77

0.67

1.38

0.80

1.40

0.92

0.001*

0.82†

0.001*

0.78†

0.993

0.02

0.118

SCL-90R Psychotic

0.57

0.50

1.39

0.75

1.33

0.80

0.001*

1.29†

0.001*

1.15†

0.925

0.07

0.228

SCL-90R GSI

0.95

0.63

1.72

0.65

1.65

0.83

0.001*

1.22†

0.001*

0.95†

0.872

0.10

0.199

SCL-90R PST

45.42

23.44

64.64

14.68

60.28

21.42

0.001*

0.98†

0.002*

0.66†

0.560

0.24

0.145

SCL-90R PSDI

1.71

0.54

2.35

0.54

2.29

0.63

0.001*

1.19†

0.001*

1.00†

0.878

0.10

0.208

TCI-R Novelty seeking

97.82

12.02

102.24

13.80

100.56

14.93

0.272

0.34

0.605

0.20

0.827

0.12

0.018

TCI-R Harm avoidance

106.72

16.68

112.12

19.07

110.96

22.87

0.393

0.30

0.562

0.21

0.958

0.06

0.014

TCI-R Reward depend.

105.54

15.68

99.82

14.77

101.90

16.75

0.196

0.38

0.515

0.22

0.804

0.13

0.022

TCI-R Persistence

109.70

15.94

112.42

22.48

122.74

21.28

0.796

0.14

0.006*

0.69†

0.040*

0.47

0.074

TCI-R Self-directedness

141.08

21.34

119.32

18.19

120.52

24.00

0.001*

1.10†

0.001*

0.91†

0.961

0.06

0.183

TCI-R Cooperativeness

139.88

13.22

134.94

16.51

130.80

19.86

0.340

0.33

0.028*

0.54†

0.468

0.23

0.048

TCI-R Self-transcend.

61.86

14.61

61.24

15.09

66.48

16.19

0.980

0.04

0.323

0.30

0.235

0.33

0.023

Suicidal behavior

n

%

n

%

n

%

p

|h|

p

|h|

p

|h|

C-V

Suicidal ideation

11

22.00%

16

32.00%

19

38.00%

0.260

0.23

0.081

0.35

0.529

0.13

0.143

Suicidal attempts

3

6.00%

4

8.00%

5

10.00%

0.695

0.08

0.461

0.15

0.727

0.07

0.060

  1. Note. SD: standard deviation. HC: healthy control. ED-A: non-athlete with an eating disorder. ED+A: athlete with eating disorder
  2. η2: Eta-squared. C-V: Cramer’s-V
  3. *Bold: significant comparison (0.05). †Bold: effect size into the ranges mild-moderate to the high-large